Clinical Trials Logo

Alzheimer Dementia clinical trials

View clinical trials related to Alzheimer Dementia.

Filter by:

NCT ID: NCT03548584 Completed - Alzheimer Dementia Clinical Trials

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Start date: May 16, 2018
Phase: Phase 3
Study type: Interventional

This study compares the efficacy of 2 doses of brexpiprazole with placebo in participants with agitation associated with dementia of the Alzheimer's type.

NCT ID: NCT03538522 Completed - Alzheimer Disease Clinical Trials

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

Start date: September 15, 2018
Phase: Phase 2
Study type: Interventional

This study seeks to evaluate the efficacy and safety of NA-83 in subjects with mild cognitive impairment due to Alzheimer's Disease

NCT ID: NCT03537729 Completed - Alzheimer Disease Clinical Trials

Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The ability to find one's way in the world is known as wayfinding. Many older adults who live in senior communities, such as independent living and assisted living residences, find wayfinding very challenging. Often times, these communities are not designed in a way that helps people find their way very easily. When people cannot find their way, they can get lost, be dependent upon others for getting out and about, or even be afraid to leave their rooms. The purpose of this study is to find out if distinctive signs and decorative elements, along with a special type of education called Spaced-Retrieval education, help residents in these communities find their way more effectively. Twelve senior communities will be assigned by chance to one of three conditions, including: 1) control - no change (the community stays the same); 2) signs and decorative elements enhanced; and 3) signs, decorative elements, and special education added. After agreeing to be in the study, the participants will be asked to find their way to certain places in their community four times over a year. Some people will be asked to participate in educational sessions on wayfinding. In addition, some people will be asked to wear a location tracker, (like a fitness tracker), for four weeks during the year. How well people find their way, along with how much they travel about within the communities, will be compared between the three groups. It is hypothesized that those in the communities with special signs and decorative elements will find their way more effectively than those in the control communities. It is also hypothesized that participants in the communities with the special education intervention will find their way better than those without the education. Finally, it is hypothesized that participants in the communities with signs and cues and education will travel about further distances than those in the control communities. The results of the study can help people who have a tendency to get lost find their way more effectively in their community, and this could result in more independence.

NCT ID: NCT03507192 Recruiting - Clinical trials for Mild Cognitive Impairment

Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.

Start date: September 25, 2017
Phase: N/A
Study type: Interventional

Muscle relaxation has been reported to be effective in alleviating anxiety and agitation symptoms in patients with dementia, but no studies have examined the effects of muscle relaxation therapy on cognitive function changes. Therefore, the purpose of this study is to compare and validate the improvement of cognitive function in patients with mild cognitive impairment and early alzheimer's dementia aged 50 to 85 years after performing muscle relaxation machine massage regularly.

NCT ID: NCT03466177 Recruiting - Alzheimer Disease Clinical Trials

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease

RetAD
Start date: March 1, 2018
Phase:
Study type: Observational

Because of a shared ontogenic origin, the retina displays similarities to the brain and spinal cord in terms of anatomy, functionality, response to insult, and immunology. Hence, the retina can be approached as an integral part of the central nervous system. The occurence of ocular manifestations in several neurodegenerative pathologies, such as Alzheimer's disease and Parkinson's disease, accentuates the strong relationship between eye and brain. Particularly retinal changes can present a substrate for cerebral changes in these disorders. Offering a 'window to the brain', the transparent eye enables non-invasive imaging of these changes in retinal structure and vasculature. In this project, the potential of retinal biomarkers for e.g. Alzheimer's will be explored with the aim to overcome some of the hurdles in the current management of these pathologies, mainly the lack of techniques for patient screening and early diagnosis. The aim of this clinical trial is to correlate the retinal biomarkers for Alzheimer's with neuro-imaging, and cognitive function. Integrating the results will yield non-invasive retinal biomarkers for clinical research, screening, and follow-up of disease progression in various neurodegenerative disorders.

NCT ID: NCT03360019 Completed - Dementia, Vascular Clinical Trials

Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support:

Start date: January 27, 2021
Phase: N/A
Study type: Interventional

In this Phase II SBIR project we will enhance a wireless WiFi-based insole that was designed and successfully tested during a Phase I trial with elderly persons with dementia and their caregivers, and then investigate its efficacy in terms of caregiver activity, burden, and quality of life in Phase II. Evaluation will use semi-structured interviews and participant observation data collected from professional and family caregivers of patients with moderate or mild dementia.

NCT ID: NCT03275363 Recruiting - Clinical trials for Mild Cognitive Impairment

The University of Hong Kong Neurocognitive Disorder Cohort

Start date: September 1, 2014
Phase: N/A
Study type: Observational [Patient Registry]

The HKU Neurocognitive Disorder (NCD) Cohort is a hospital-based, prospective, observational study of older HK Chinese adults with cognitive impairment, with a special focus on studying patients with subjective cognitive decline and mild cognitive impairment.

NCT ID: NCT03255720 Not yet recruiting - Alzheimer Dementia Clinical Trials

Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes

Start date: September 29, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Diffusion Tensor imaging of white matter degeneration in Alzheimer disease

NCT ID: NCT03132272 Terminated - Alzheimer Dementia Clinical Trials

Immunoadsorption for Treatment of Alzheimer's Disease

IMAD
Start date: September 15, 2016
Phase: N/A
Study type: Interventional

Efficacy of immunoadsorption for treatment of persons with Alzheimer dementia and agonistic autoantibodies against alpha1A-adrenoceptor.

NCT ID: NCT03044249 Terminated - Dementia Clinical Trials

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Start date: May 4, 2017
Phase: Phase 2
Study type: Interventional

A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression